Gene · 8720
Papers2,858
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,858
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Endothelial Collapse as a Convergent Immunovascular Phenotype in Sepsis and Severe Arboviral Disease: The SIMVAC Model. | Pathogens | 2026 | 42796720 | PubTator, text mining | PubMed |
| Combined Modulation of Ceramide and S1P Pathways Induces Strong Cytotoxicity in SH-SY5Y Neuroblastoma Cells. | Int J Mol Sci | 2026 | 42794556 | PubTator, text mining | PubMed |
| Sphingolipid Remodeling in Colorectal Cancer Reveals a Continuum-like Metabolic Organization. | Antioxidants (Basel) | 2026 | 42792175 | PubTator, text mining | PubMed |
| Hyaluronidase-enhanced delivery in gene therapy and regenerative medicine for improved vector, cell, and cargo access. | Front Drug Deliv | 2026 | 42756066 | PubTator, text mining | PubMed |
| C/EBPδ regulates SPHK1-dependent excessive autophagy in decidualization defects of chronic endometritis. | Reproduction | 2026 | 42704675 | PubTator, text mining | PubMed |
| Roles of Ceramide Glucosyltransferase in Controlling Cerebral Microvascular Endothelial Integrity and Angiogenesis Post-Ischemia/Reperfusion. | Transl Stroke Res | 2026 | 42625084 | PubTator, text mining | PubMed |
| Therapeutic targeting of G protein-coupled receptors in central nervous system disorders: from novel mechanisms to precision pharmacology. | Eur J Pharmacol | 2026 | 42624449 | PubTator, text mining | PubMed |
| Erratum: Macrophage polarization involved the inflammation of chronic obstructive pulmonary disease by S1P/HDAC1 signaling. | Am J Cancer Res | 2026 | 42597431 | PubTator, text mining | PubMed |
| Extracellular Vesicles in Cardiovascular Disease: Intercellular Signaling, Liquid Biopsy Biomarkers, and Therapeutic Translation. | Circ Res | 2026 | 42594169 | PubTator, text mining | PubMed |
| Liver reprogramming toward hepatocellular carcinoma following hepatitis C sustained virologic response: a narrative review. | Transl Gastroenterol Hepatol | 2026 | 42592470 | PubTator, text mining | PubMed |
| Pyrogallol inhibits T cell lymphoma growth by mediating G2/M phase cell cycle arrest, apoptosis, glycolysis and immune evasion: an implication of AKT pathway. | Cytotechnology | 2026 | 42471957 | PubTator, text mining | PubMed |
| Disrupted erythrocyte S1P-eNOS axis promotes hypoxia, hypertension and fibrosis in obstructive sleep apnoea-hypopnoea syndrome. | Eur Heart J | 2026 | 42412527 | PubTator, text mining | PubMed |
| APOM-S1P axis as a therapeutic target in steroid sensitive nephrotic syndrome. | Pediatr Nephrol | 2026 | 42400614 | PubTator, text mining | PubMed |
| Research progress and mechanistic exploration of Ophiopogon japonicus polysaccharides in the treatment of obesity-related diabetes and cardiovascular diseases: A narrative review. | Int J Biol Macromol | 2026 | 42392392 | PubTator, text mining | PubMed |
| Unlocking the healing power of Berberine: A promising aid for multiple sclerosis. | IBRO Neurosci Rep | 2026 | 42381886 | PubTator, text mining | PubMed |
| Transcriptomic profiling of an in vivo diffuse large B-cell lymphoma model reveals molecular programs underlying CNS dissemination. | Ann Hematol | 2026 | 42380537 | PubTator, text mining | PubMed |
| Classification of recurrent implantation failure patients using peripheral blood immunological and metabolic markers. | Bioimpacts | 2026 | 42371523 | PubTator, text mining | PubMed |
| Bowel Urgency in Inflammatory Bowel Disease: Prevalence, Psychosocial Burden, and Challenges in Assessment. | J Gastrointestin Liver Dis | 2026 | 42365647 | PubTator, text mining | PubMed |
| Ceramide-Driven Mechanisms in Pulmonary Fibrosis. | Metabolites | 2026 | 42346401 | PubTator, text mining | PubMed |
| Beyond resorption: targeting osteoclast fusion and polarization to restore balanced bone remodeling. | Front Pharmacol | 2026 | 42328629 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8720/papers